ISTH 2017 Program Topics
ISTH 2017 will be the premier scientific event in the field of thrombosis, hemostasis and wider benign hematology. The event will address the immediate and future scientific, laboratory and clinical opportunities and challenges.
ISTH meetings accomplish this by bringing together thousands of clinicians and researchers as well as young scientists, nurses and allied-health professionals from around the globe who present their latest discoveries to advance the scientific understanding and translate scientific knowledge into new approaches to diagnosis and treatment of thrombotic and bleeding disorders.
The outstanding congress program will foster this sharing of knowledge and advancing scientific discoveries through an extensive line-up of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities.
ISTH meetings accomplish this by bringing together thousands of clinicians and researchers as well as young scientists, nurses and allied-health professionals from around the globe who present their latest discoveries to advance the scientific understanding and translate scientific knowledge into new approaches to diagnosis and treatment of thrombotic and bleeding disorders.
The outstanding congress program will foster this sharing of knowledge and advancing scientific discoveries through an extensive line-up of educational sessions, poster and oral communications, state-of-the-art lectures, medical industry exhibits and professional networking opportunities.
The following areas in thrombosis and hemostasis will be covered:
|
|
|
Atherothrombosis & Stroke
Atherosclerosis Cardiovascular Risk Factors Ischemia-reperfusion Injury Myocardial Infarction Peripheral Vascular Disease Stroke Coagulant & Anticoagulant Mechanisms Animal Models in Thrombosis & Hemostasis Coagulation Factors and Inhibitors Coagulation Proteins Beyond Hemostasis Contact Pathway FVIII/IX Protein C Pathway Regulation of Coagulation Tissue Factor Pathway Coagulation Signaling & Immunity Complement and Hemostatic System Hemostatic Signaling Infection & Hemostatic Factors Inflammation and Sepsis Innate & Adaptive Immunity Platelets & Inflammation Protease Activated Receptors Diagnostics and OMICs Bioinformatics & Systems Biology Biomarkers of Thrombosis & Haemostasis Epigenetics Laboratory Diagnostic Nanotechnology OMICs Fibrinolysis & Proteolysis Cellular & Tumor Proteases Coagulation and Cancer Fibrinogen and Factor XIII Fibrinolytic Factors and Inhibitors Thrombolytic Therapy Hemorrhagic Disorders, Hemophilia Acquired Hemorrhagic Coagulation Disorders Disseminated Intravascular Coagulation Hemophilia - Basic Hemophilia - Clinical Hemophilia Gene Therapy Hemorrhagic Disorders, Pediatric Aspects Management of Bleeding & Trauma Novel Biotherapeutics in Hemophilia Rare Bleeding Disorders VWF and von Willebrand Disease |
Management of Thromboembolism
Atrial Fibrillation DOACs Heparins & Heparinoids Novel Anticoagulants Post-thrombotic Syndrome Pregnancy Complications Thromboembolism, Pediatric Aspects Vitamin K Antagonists Nurses and Allied Health Pathogenesis of Thromboembolism Antiphospholipid Syndrome Cancer-Associated Thrombosis Genetic Risk Factors of Thrombosis Hemostasis & Organ Dysfunction Microparticles Thrombophilia Pediatrics Diagnosis and management of inherited bleeding disorders in children Diagnosis and management of acquired bleeding disorders in children Epidemiology of pediatric thrombosis Diagnosis of pediatric thrombosis Anticoagulant prophylaxis and treatment in children Platelets – Basic Megakaryotes & Thrombopoiesis Platelet Antagonists Platelets Beyond Hemostasis Platelet Function and Interactions Platelet Proteomics and Genomics Platelet Receptors Platelet Signaling Platelets – Clinical ADAMTS13/TTP Antiplatelet Therapy HIT and ITP HUS/Thrombotic Microangiopathies Platelet Disorders, Acquired Platelet Disorders, Inherited Platelets, Pediatric Aspects Transfusion & Biotherapeutics Blood Components, Production and Substitution Cellular Therapies & Blood Cell Farming Novel Biomolecules Patient Blood Management Safety & Inactivation of Blood Components Vascular Biology & Angiogenesis Angiogenesis & Vasculogenesis Blood Cells and Vessel Wall Endothelial Cell Signaling Non-coding RNAs Vascular Progenitor and Stem Cells |